Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The Company is engaged in developing a pipeline of medicines for rare metabolic diseases,... Read more
Yahoo
CNBC
MarketWatch
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.